Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

21 Jan 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated January 21, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Capsules USP, 10 mEq’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..